Pelvic venous thrombosis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:24:44 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Pelvic venous thrombosis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis. https://clinicaltrials.eu/trial/a-study-to-evaluate-the-use-of-colchicine-to-reduce-inflammation-in-patients-with-deep-vein-thrombosis/ Wed, 29 Apr 2026 15:10:06 +0000 https://clinicaltrials.eu/trial/a-study-to-evaluate-the-use-of-colchicine-to-reduce-inflammation-in-patients-with-deep-vein-thrombosis/ This study focuses on Deep Vein Thrombosis, a condition where a blood clot forms in a deep vein, typically in the legs. A common long-term complication of this condition is Post-thrombotic syndrome, which is a set of symptoms like swelling, pain, and skin changes that can occur after the clot has been treated. The purpose of the study is to evaluate if taking a low dose of colchicine can help reduce the risk of developing this syndrome.

Participants in the study will be assigned to receive either a 0.5 mg tablet of colchicine once a day or a placebo once a day. The study will monitor participants over a period of time to observe the effects of the medication on their health and to check for any possible side effects. This process involves tracking various health outcomes to see how the treatment compares to the inactive pill.

]]> Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism https://clinicaltrials.eu/trial/study-on-rosuvastatin-for-reducing-blood-clots-in-patients-with-deep-vein-thrombosis-or-pulmonary-embolism/ Wed, 29 Apr 2026 14:30:35 +0000 https://clinicaltrials.eu/trial/study-on-rosuvastatin-for-reducing-blood-clots-in-patients-with-deep-vein-thrombosis-or-pulmonary-embolism/ This clinical trial is focused on studying the effects of a medication called Rosuvastatin Calcium in patients who have experienced certain types of blood clots. The diseases being studied include Pulmonary Embolism, Venous Thromboembolism, and Deep Vein Thrombosis. These conditions involve the formation of blood clots in the veins, which can be serious and require medical attention. The trial will compare the effects of Rosuvastatin Calcium to a placebo, which is a substance with no active medication, to see if the medication can help reduce the occurrence of these blood clots.

The purpose of the study is to determine if taking Rosuvastatin Calcium can lower the rate of major blood clot events in patients who have already had a clot. Participants in the study will be randomly assigned to receive either Rosuvastatin Calcium or a placebo. The study will monitor the participants over a period of time to observe any differences in the recurrence of blood clots between the two groups. The trial will also look at other health outcomes, such as the development of post-thrombotic syndrome, which is a condition that can occur after a blood clot, and other vascular events like heart attacks or strokes.

Throughout the study, participants will be regularly checked to ensure their safety and to gather information on how the medication is affecting their health. The trial is expected to continue until the end of 2027, providing valuable insights into the potential benefits of Rosuvastatin Calcium for patients with these types of blood clots.

]]>